Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat

Virology

Volumn 227, Issue 2, 1997, Pages 331-342

  Faller, Douglas V ^a   Weng, Haiqin ^a   Choi, Sang Yun ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; ONCOVIRINAE; UNIDENTIFIED RETROVIRUS;

EID: 0031579236     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8345     Document Type: Article

References (68)

1. Alexander, C. M., and Werb, Z. (1992). Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro. J. Cell Bol. 118, 727-739.
2. Angel, P., Baumann, I., Stein, B., Delius, H., Rahmsdorf, H. J., and Herrlich, P. (1987). 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol. Cell Biol. 7, 2256-2266.
3. Angel, P., Hattori, K., Smael, T., and Karin, M. (1988). The jun protooncogene is positively autoregulated by its product, jun/AP-1. Cell 55, 875-885.
4. Angel, P., and Karin, M. (1992). Specific members of the Jun protein family regulate collagenase expression in response to various extracellular stimuli. Matrix Suppl. 1, 156-164.
5. Auble, D., and Brinckerhoff, C. E. (1991). The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. Biochemistry 30, 4629-4636.
6. Belli, B., Wolff, L., Nazarov, V., and Fan, H. (1995). Proviral activation of the c-myb proto-oncogene is detectable in preleukemic mice infected neonatally with Moloney murine leukemia virus but not in resulting end stage T lymphomas. J. Virol. 69, 5138-5141.
7. Brightman, B. K., Davis, B. R., and Fan, H. (1990). Preleukemic hematopoietic hyperplasia induced by Moloney murine leukemia virus is an indirect consequence of viral infection. J. Virol. 64, 4582-4584.
8. Brooks, P. C., Stromblad, S., Sanders, L. C., vonSchalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., and Cheresh, D. A. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85, 683-693.
9. Cepko, C. L., Roberts, B. E., and Mulligan, R. C. (1984). Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell 37, 1053-1062.
10. Chamberlain, S. H., Hemmer, R. M., and Brinckerhoff, C. E. (1993). Novel phorbol ester response region in the collagenase promoter binds Fos and Jun. J. Cell Biochem. 52, 337-351.
11. Chattopadhyay, S. K., Oliff, A. I., Linemeyer, D. L., Lander, M. R., and Lowy, D. R. (1981). Genomes of murine leukemia viruses isolated from wild mice. J. Virol. 39, 777-791.
12. Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., and Rutter, W. J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
13. Choi, S. Y., van de Mark, K. A., and Faller, D. V. (1996). Identification of the cis-acting element of the class I Major Histocompatibility Complex promoter responsive to activation by retroviral sequences. J. Virol., in press.
14. Choi, S. Y., and Faller, D. V. (1994). The long terminal repeats of a murine retrovirus encode a trans-activator for cellular genes. J. Biol. Chem. 269, 19691-19694.
15. Choi, S. Y., and Faller, D. V. (1995). A transcript from the long terminal repeats of a murine retrovirus associated with trans-activation of cellular genes. J. Virol. 69, 7054-7060.
16. Chumakov, I., Stuhlmann, H., Harbers, K., and Jaenisch, R. J. (1982). Cloning of two genetically transmitted Moloney leukemia proviral genomes: correlation between biological activity of the cloned DNA and viral genome activation in the animal. J. Virol. 42, 1088-1098.
17. Cuypers, H. T., Selten, G., Quint, W., Zijlstra, M., Maandag, E. R., Boelens, W., van Wezenbeek, P., Melief, C., and Berns, A. (1994). Murine leukemia virus-induced T-cell lymphomagenesis: integration of provirus in a distinct chromosomal region. Cell 37, 141-150.
18. Darmiento, J., Dicolandrea, T., Dalal, S.S., Okada, Y., Huang, M. T., Conney, A. M., and Chada, K. (1995). Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol. Cell Biol. 15, 5732-5739.
19. Davis, B. R., Brightman, B. K., Chandy, K. G., and Fan, H. (1987). Characterization of a preleukemic state induced by Moloney murine leukemia virus: Evidence for two infection events during leukemogenesis.. Proc. Natl. Acad. Sci. USA 84, 4875-4879.
20. Devarajan, P., Johnston, J. J., Ginsberg, S. S., Vanwart, H. E., and Berliner, N. (1992). Structure and expression of neutrophil gelatinase cDNA-Identity with type IV collagenase from HT1080 cells. J. Biol. Chem. 267, 25228-25232.
21. Faller, D. V., Wilson, L. D., and Flyer, D. C. (1988). Mechanism of induction of class I major histocompatibility antigen expression by murine leukemia virus. J. Cell Biochem. 36, 297-309.
22. Fan, H. (1990). Influences of the long terminal repeats on retroviral pathogenicity. Semin. Virol. 1, 164-174.
23. Feinberg, A. P., and Vogelstein, B. (1983). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13.
24. Flyer, D. C., Burakoff, S. J., and Faller, D. V. (1983). Expression of transfected viral glycoprotein genes on the cell surface; recognition and killing by virus-specific cytotoxic T-lymphocytes. Nature 305, 315-318.
25. Flyer, D. C., Burakoff, S. J., and Faller, D. V. (1985). Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. J Immunol. 135, 2287-2292.
26. Gack, S., Vallon, R., Schaper, J., Ruther, U., and Angel, P. (1994). Phenotypic alterations in Fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression-Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein. J Biol. Chem. 269, 10363-10369.
27. Garry, R. F. (1994). New evidence for involvement of retroviruses in Sjogren's syndrome and other autoimmune diseases [editorial]. Arthritis Rheum. 37, 465-469.
28. Goldberg, G., Marmer, B., Grant, G., Eisen, A., Wilhelm, S., and He, C. (1989). Human 72-kilodalton type IV collagenase forms a complex with the tissue inhibitor of metalloproteases designated TIMP-2. Proc. Natl. Acad. Sci. USA 86, 8207-8211.
29. German, C. M., Moffat, L. F., and Howard, B. H. (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell Biol. 2, 1044-1051.
30. Gray, S. T., Wilkins, R. J., and Yun, K. (1992). Interstitial collagenase gene expression in oral squamous cell carcinoma. Am. J. Pathol. 141, 301-306.
31. Hayward, W. S., Neel, B. G., and Astrin, S. M. (1981). Activation of a cellular one gene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290, 475-480.
32. Hendrix, M. J. C., Seftor, E. A., Grogan, T. M., Seftor, R. E. B., Hersh, E. M., Boyse, E. A., Liotta, L. A., Stetler-Stevenson, W., and Ray, C. G. (1992). Expression of type-IV collagenase correlates with the invasion of human lymphoblastoid cell lines and pathogenesis in SCID mice. Mol. Cell Probe 6, 59-65.
33. Higashino, F., Yoshida, K., Noumi, T., Seiki, M., and Fujinaga, K. (1995). Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 10, 1461-1463.
34. Imai, K., Ohuchi, E., Aoki, T., Nomura, H., Fujii, Y., Sato, H., Seiki, M., and Okada, Y. (1996). Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res. 56, 2707-2710.
35. Izui, S., Masuda, K., Yoshida, H., Kelly, V. E., Roths, J. B., and Hara, I. (1984). "Recent Advances in Systemic Lupus Erythrematosis" (P. H. Lambert, L. Perrin, and S. Izui, Eds.). Academic Press, New York.
36. Karelina, T. V., Hruza, G. J., Goldberg, G. I., and Eisen, A. Z. (1993). Localization of 92-kDa type-IV collagenase in human skin tumors-Comparison with normal human fetal and adult skin. J. Invest. Dermatol. 100, 159-165.
37. Kennedy-Stoskopf, S., Zink, M. C., Jolly, P. E., and Narayan, O. (1987). Lentivirus-induced arthritis: chronic disease caused by a covert pathogen. Rheum. Dis. Clin. North Am. 48, 89-91.
38. Kobayashi, M., Hamada, J, Li, Y. Q., Shinobu, N., Imamura, M., Okada, F., Takeichi, N., and Hosokawa, M. (1995). A possible role of 92 kDa type IV collagenase in the extramedullary tumor formation in leukemia. Jpn. J. Cancer Res. 86, 298-303.
39. Koka, P., van de Mark, K. A., and Faller, D. V. (1991). Trans-activation of genes encoding activation-associated human T lymphocyte surface proteins by murine retroviral sequences. J. Immunol. 146, 2417-2425.
40. Konig, H., Ponta, H., Rahmsdorf, H. J., and Herrlich, P. (1992). Interference between pathway-specific transcription factors - Glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J. 11, 2241-2246.
41. Li, J., and Baltimore, D. (1991). Mechanisms of leukemogenesis induced by mink cell focus-forming murine leukemia viruses. J. Virol. 65, 2408-2414.
42. Liotta, L., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C., and Shafie, S. (1980). Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284, 67-68.
43. Liotta, L., Tryggvason, K., Garbisa, S., Rohey, P. G., and Abe, S. (1981). Partial purification and characterization of a neutral protease which cleaves type IV collagen. Biochemistry 20, 100-108.
44. Liotta, L., Guirguis, R., and Strake, M. (1987). Biology of melanoma invasion and metastasis. Pigmented Cell Res. 1, 5-15.
45. Lowy, D. R., Rands, E., Chattopadhyay, S. K., Garon, C. F., and Hager, G. L. (1980). Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells. Proc. Natl. Acad. Sci. USA 77, 614.
46. Nazarov, V., Hilbert, D., and Wolff, L. (1994). Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia. Virology 205, 479-485.
47. Nelson, P. N. (1995). Retroviruses in rheumatic diseases. Ann. Rheum. Dis. 54, 441-442.
48. Oprian, D. D., Molday, R. S., Kaufman, R. J., and Khorana, H. G. (1987). Expression of a synthetic bovine rhodopsin gene in monkey kidney cells. Proc. Natl. Acad. Sci. USA 84, 8874-8878.
49. Paine, M. L., Gibbins, J. R., Whitelock, J. M., Ogrady, R. L., and Kefford, R. F. (1993). Unregulated and independent expression of collagenase and transin related to tumor progression. J. Natl. Cancer Inst. 85, 1425-1427.
50. Petrarca, M. A., Reiss, C. S., Diamond, D. C., Boni, J., Burakoff, S. J., and Faller, D. V. (1988). T cell hybridomas define the class II MHC-restricted response to vesicular stomatitis virus infection. Microb. Pathog. 5, 319-332.
51. Poste, G., and Fidler, I. (1980). The pathogenesis of cancer metastasis. Nature 283, 139-146.
52. Pourmotabbed, T., Solomon, T. L., Hasty, K. A., and Mainardi, C. L. (1994). Characteristics of 92 kDa type IVcollagenase/gelatinase produced by granulocytic leukemia cells-Structure, expression of cDNA in E-coli and enzymic properties. Bba-Protein Struct. Mol. Enzym. 1204, 97-107.
53. Rommelaere, J., Faller, D. V., and Hopkins, N. (1978). Characterization and mapping of RNase T1-resistant oligonucleotides derived from the genomes of Akv and MCF murine leukemia viruses. Proc. Natl. Acad. Sci. USA 75, 495-499.
54. Rowe, I. R., and Keat, A. C. S. (1989). Human immunodeficiency virus infection and the rheumatologist. Ann. Rheum. Dis. 48, 89-91.
55. Salo, T., Liotta, L., and Tryggvason, K. (1981). Purification and characterization of a murine basement collagen-degrading enzyme secreted by metastatic tumor cells. J. Biol. Chem. 258, 3058-3063.
56. Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
57. Sato, H., Kita, M., and Seiki, M. (1993). v-Src Activates the expression of 92-kDa type-IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements-A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 268, 23460-23468.
58. Schonthal, A., Herrlich, P., Rahmsdorf, H. J., and Ponta, H. (1988). Requirement for c-fos gene expression in transcriptional activation of collagenase by other oncogenes and phorbol ester. Cell 54, 325.
59. Shen-Ong, G. L., and Wolff, L. (1987). Moloney murine leukemia virus-induced myeloid tumors in adult BALB/c mice; Requirement of c-myb activation but lack of v-abl involvement. J. Virol. 61, 3721-3725.
60. Shinnick, T. M., Lerner, R. A., and Sutcliffe, J. C. (1981). Nucleotide sequence of Moloney murine leukemia virus. Nature 293, 543.
61. Stearns, M. E., and Stearns, M. (1993). Autocrine factors, type-IV collagenase secretion and prostatic cancer cell invasion. Cancer Met. Rev. 12, 39-52.
62. Watanabe, H., Nakanishi, I., Yamashita, K., Hayakawa, T., and Okada, Y. (1993). Matrix metalloproteinase-9 (92kDa Gelatinase/Type-IV Collagenase) from U937 monoblastoid cells-Correlation with cellular invasion. J. Cell Sci. 104, 991-999.
63. Weeks, B. S., Klotman, M. E., Holloway, E., Stetler-Stevenson, W. G., Kleinman, H. K., and Klotman, P. E. (1993a). HIV-1 infection stimulates T-cell invasiveness and synthesis of the 92-kDatype-IV collagenase. AIDS Res. Hum. Retroviruses 9, 513-518.
64. Weeks, B. S., Schnaper, H. W., Handy, M., Holloway, E., and Kleinman, H. K. (1993b). Human T-lymphocytes synthesize the 92-kDa type-IV collagenase (gelatinase-B). J. Cell Physiol. 157, 644-649.
65. Weng, H. Q., Choi, S. Y., and Faller, D. V. (1995). The Moloney leukemia retroviral long terminal repeat trans-activates AP-1-inducible genes and AP-1 transcription factor binding. J. Biol. Chem. 270, 13637-13644.
66. Wilder, R. L. (1994). Hypothesis for retroviral causation of rheumatoid arthritis. Curr. Opin. Rheumatol. 6, 295-299.
67. Wilson, L. D., Flyer, D. C., and Faller, D. V. (1987). Murine retrovirus control class I MHC expression via a trans effect at the transcriptional level. Mol. Cell Biol. 7, 2406-2415.
68. Xia, M. H., Sreedharan, S. P., Dazin, P., Damsky, C. H., and Goetzl, E. J. (1996). Integrin-dependent role of human T cell matrix metalloproteinase activity in chemotaxis through a model basement membrane. J. Cell Biochem. 61, 452-458.